Getinge USA Announces Contract With Memorial Hermann Healthcare System
Getinge USA, Inc. has signed a multi-year contract with Memorial Hermann Healthcare System in Houston, Texas. The $15 million contract covers infection control equipment, service and consumables, signifying one of the largest contracts for Getinge USA in recent history.
The agreement highlights Getinge as the sole provider to the central sterile supply departments in all of Memorial Hermann’s facilities. Evolved from a long business relationship between the two entities, the pact represents both consolidation and extension of three independent contracts between the two groups.
“We feel that Getinge is a partner that always delivers more than one can expect. Their service is outstanding. The price guarantee that we get through this contract is very valuable and something that we can pass on to our end-users,” says Shirley Arthur, manager of capital purchasing for Memorial Hermann Healthcare System.
“We are incredibly proud. This is a fantastic reference and a good testament to the Getinge value proposition,” says Charles Burrage, sales service executive at Getinge USA. “The relationship we have with the Memorial Hermann is quite unique. They have made a big commitment to us by signing this contract, and we have made a big commitment to them. The longevity of our relationship, over 20 years with this new contract, is unique in this competitive world.”
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
